GFAP Expression as an Indicator of Disease Severity in Mouse Models of Alexander Disease

by Paige L. Jany, Tracy L. Hagemann, Albee Messing
Published 2013-02-01

Genetic ablation of Nrf2/antioxidant response pathway in Alexander disease mice reduces hippocampal gliosis but does not impact survival.

by Tracy L Hagemann, Emily M Jobe, Albee Messing
Published 2012-01-01

Caspase Cleavage of GFAP Produces an Assembly-Compromised Proteolytic Fragment that Promotes Filament Aggregation

by Mei-Hsuan Chen, Tracy L. Hagemann, Roy A. Quinlan, Albee Messing, Ming-Der Perng
Published 2013-10-01

Pexidartinib treatment in Alexander disease model mice reduces macrophage numbers and increases glial fibrillary acidic protein levels, yet has minimal impact on other disease phen...

by Michelle M. Boyd, Suzanne J. Litscher, Laura L. Seitz, Albee Messing, Tracy L. Hagemann, Lara S. Collier
Published 2021-03-01

Tissue and cellular rigidity and mechanosensitive signaling activation in Alexander disease

by Liqun Wang, Jing Xia, Jonathan Li, Tracy L. Hagemann, Jeffrey R. Jones, Ernest Fraenkel, David A. Weitz, Su-Chun Zhang, Albee Messing, Mel B. Feany
Published 2018-05-01